4
Changes in Ownership
Benitec Biopharma Inc. Filed Acc 0001062993-24-020462
Options or other derivatives
- Executive Director acquired 720,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Boston Megan Executive Director | 2024-12-09 | Grant or award · Options (right to buy) | +720,000 | 720,000 | D | ||
Loading xslF345X05/form4.xml…